Evidence map›Paper›PMID 36357406›Full record

ArticleScientific reports2022

Synthesis of CoFe

Ali Modabberasl, Tahereh Pirhoushyaran, Seyyed Hamid Esmaeili-Faraj

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Optimization of CoFeNanoscale advances · 2024
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ali ModabberaslDepartment of Physics, College of Sciences, Yasouj University, Yasouj, 7591874831, Iran.
Tahereh PirhoushyaranDepartment of Chemical Engineering, Dezful Branch, Islamic Azad University, Dezful, Iran.
Seyyed Hamid Esmaeili-FarajFaculty of Material and Chemical Engineering, Shahrood University of Technology, Shahrood, 3619995161, Iran. h.esmaeili@shahroodut.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azithromycin is one of the most widely used antibiotics in medicine prescribed for various infectious diseases such as COVID-19. A significant amount of this drug is always disposed of in hospital effluents. In this study, the removal of azithromycin using Cobalt-Ferrite magnetic nanoparticles (MNP) is investigated in the presence of UV light. For this purpose, magnetic nanoparticles are synthesized and added to the test samples as a catalyst in specific proportions. To determine the structural and morphological properties of nanoparticles, characterization tests including scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), vibrating-sample magnetometer (VSM), and Energy-dispersive X-ray spectroscopy (EDX) are performed. 27 runs have been implemented based on the design of experiments using the Box-Behnken Design (BBD) method. Parameters are the initial concentration of azithromycin (20-60 mg/L), contact time (30-90 min), pH (6-10), and the dose of magnetic nanoparticles (20-60 mg/L). The obtained model interprets test results with high accuracy (R

Indexed as

COVID-19Magnetite NanoparticlesAzithromycinCOVID-19 Drug TreatmentHumansSpectroscopy, Fourier Transform InfraredWastewaterAzithromycinMagnetite NanoparticlesWastewater

Identifiers

PMID36357406
PMCPMC9647251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.